期刊文献+

输尿管部分切除术治疗原发性输尿管癌临床疗效分析(附14例报告) 被引量:6

Clinical Analysis of Partial Ureteral Resection for Primary Ureteral Carcinoma(Report of 14 Cases)
原文传递
导出
摘要 目的:探讨保留肾脏的输尿管部分切除术治疗原发性输尿管癌的可行性及疗效。方法:回顾性分析2000年4月~2010年4月14例输尿管中下段癌患者行保留肾脏的输尿管部分切除术(治疗组)的临床资料。从术后膀胱癌发生率、疾病特异性生存率等方面与同期29例行输尿管癌根治术(对照组)进行比较。结果:治疗组12例获得随访,术后膀胱癌发生率为16.7%(2/12),疾病特异性生存率1年为91.7%(11/12),5年为75.0%。对照组24例获随访,术后膀胱癌发生率为12.5%(3/24),疾病特异性生存率1年为95.8%(23/24),5年为79.2%。两组术后膀胱癌发生率及1年、5年疾病特异性生存率比较差异均无统计学意义(均P>0.05)。结论:基于输尿管癌双侧致病同步及异时性特点,在能严格随访的条件下,输尿管部分切除术+输尿管连续性的重建可以应用于适当选择的中下段输尿管癌患者。 Objective:To evaluate the feasibility and efficacy of partial ureteral resection for primary ureteral carcinoma. Method:From April 2000 to April 2010,14 cases of primary ureterai carcinoma were retrospectively investigated. This series included 14 cases of primary ureteral carcinoma who had undergone partial ureteral resec- tion,and then restored the continuity of the ureter. The middle ureteral cancer used the ileum restored the continui- ty of the ureter,and the lower ureteral cancer used the bladder flap restored the continuity of the ureter. And 29 ca- ses who had undergone radical nephroureterectomy for primary ureteral carcinoma(control group)at the same time. The incidence of bladder cancer after operation, the disease specific survival rate were compared between the 2 groups. Result : Follow-up was available in 12 cases of partial ureteral resection group, the incidence of bladder canc- er after operation is 16.7%(2/12) ,the disease specific 1-year survival rate is 91.7%(11/12) ,and the disease spe- cific 5-year survival rate is 75.0 %. Follow-up was available in 24 cases of control group, the incidence of bladder cancer after operation is 12.5%(3/24) ,the disease specific 1-year survival rate is 95.8%(23/24) ,the disease spe cific 5-year survival rate is 79.2%. There was no obvious difference in the incidence of bladder cancer after opera tion, the disease specific l-year and 5-year survival rate between the 2 groups(P:〉0.05). Conclusion: Based on dis- ease characteristics of synchronous and metachronous and bilateral of the ureteral carcinoma,and with strictly fol- low-up after partial ureteral resection for primary ureteral carcinoma, partial ureteral resection and restore the con- tinuity of the ureter can be used in properly selected patients with middle and lower ureteral carcinomas.
出处 《临床泌尿外科杂志》 北大核心 2011年第10期750-751,756,共3页 Journal of Clinical Urology
关键词 输尿管肿瘤 输尿管部分切除术 临床疗效 ureteral carcinoma partial ureteral resection clinical efficacy
  • 相关文献

参考文献7

  • 1Kirkali Z,Tuzel E.Transitional cell carcinoma of the ureter and renal pelvis[J].Crit Rev Oncol Hematol,2003,47:155-169.
  • 2Iborra I,Solsona E,Casanova J,et al.Conservative elec-tive treatment of upper urinary tract tumours:a multivariate analysis of prognostic factors for recurrence and progression[J].J Urol,2003,169:82-85.
  • 3Soderdahl D W,Fabrizio M D,Rahman N U,et al.Endoscopic treatment of upper tract transitional cell carcinoma[J].Urol Oncol,2005,23:114-122.
  • 4Murta C B,Antunes A A,Dall'oglio M F,et al.Analysis of the clinicopathological characteristics of patients with upper urinary tract transitional cell carcinoma[J].Clinics(Sao Paulo),2008,63:223-228.
  • 5Giannarini G,Schumacher M C,Thalmann G N,et al.Elective management of transitional cell carcinoma of the distal meter:can kidney-sparing surgery be advised[J] ? BJU Int,2007,100:264-268.
  • 6Yang M H,Chen K K,Yen C C,et al.Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan[J].Urology,2002,59:681-687.
  • 7Wright J L,Hotaling J,Porter M P.Predictors of upper tract urothelial cell carcinoma after primary bladder cancer:a population based analysis[J].J Urol,2009,181:1035-1039.

同被引文献71

  • 1张争,潘柏年.原发性输尿管癌影响预后因素分析[J].中华泌尿外科杂志,2004,25(12):838-840. 被引量:19
  • 2潘柏年,张争,刘玉立,郭应禄.174例原发性输尿管癌的临床分析[J].中华外科杂志,2004,42(23):1447-1449. 被引量:59
  • 3张玉石,李汉忠,张锐强,纪志刚.伴有肾功能不全的上尿路移行细胞癌的诊断和治疗(附42例报告)[J].临床泌尿外科杂志,2007,22(9):673-675. 被引量:2
  • 4关有彦,李宁忱,周利群,何志嵩,李鸣,那彦群.输尿管癌预后相关因素的临床研究[J].中华外科杂志,2007,45(18):1260-1263. 被引量:5
  • 5Ni(t)(a)G,Georgescu D,Mul escu R,et al.Prognostic factors in laser treatment of upper urinary tract urothelial tumours.J Med Life.2012 Feb 22;5(1):33~8.
  • 6Xu AD,Ng CS,Kamat A,Grossman HB,Dinney C,Sandler CM.Significance of upper urinary tract urothelial thickening and filling defect seen on MDCT urography in patients with a history of urothelial neoplasms.AJR Am J Roentgenol.2010 Oct;195(4):959~65.
  • 7Messer J,Lin YK,Raman JD.The role of lymphadenectomy for upper tract urothelial carcinoma.Nat Rev Urol.2011 May 24;8(7):394~401.
  • 8Munoz JJ,Ellison LM.Upper tract urothelial neoplasms:incidence and survival during the last 2 decades[J].J Urol,2000; 164(5):1523~1525.
  • 9Oosterlinck W,Solsona E,Vander Meijden AP,et al EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma Eur Urol,2004;46(2):147~154.
  • 10O'Brien T,Ray E,Singh R,et al.Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma:a prospective,multicentre,randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial).Eur Urol.2011Oct;60(4):703~10.

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部